WeCare zinc oxide ointment recalled over good manufacturing practice deviations
Blossom Pharmaceuticals is recalling 2,592 bottles of WeCare Zinc Oxide Ointment, 15 oz, over current good manufacturing practice deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record cites current good manufacturing practice deviations with no stated product defect or reported harm.
Plain-English summary
WeCare Zinc Oxide Ointment, net weight 15 oz (425 g), made in India and manufactured for Dynarex Corporation of Middletown, New York, under NDC 67777-223-05, is being recalled.
The reason given in the enforcement record is cGMP deviations.
The recall covers 2,592 bottles from lots A062434, expiry 6/27, and A062449, expiry 7/27. Distribution was nationwide in the USA. The FDA has classified the action as Class II.
The record cites manufacturing practice deviations without describing a specific product defect, and states no injuries. Customers should follow the firm's instructions.
The recalled product
- Product
- ZINC OXIDE (ZINC OXIDE OINTMENT)
- Brand
- ZINC OXIDE
- Manufacturer
- Blossom Pharmaceuticals
- Category
- Drug — Skin protectant
- Affected units
- 2,592
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: A062434
- Exp. Date 6/27 & A062449
- Exp. Date 7/27
UPCs (3)
- 0616784119113
- 0616784119014
- 0616784119212
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by Blossom Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Blossom Pharmaceuticals
See all →- ModerateClotrimazole cream, 1 ounce size, recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateWound hydrogel recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateDynashield Skin Protectant, 16 ounce size, recalled over manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateLanashield Skin Barrier recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateNivagen zinc oxide ointment recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19